Literature DB >> 15166267

Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry.

H A Gietema1, R J C L M Vuylsteke, I A de Jonge, P A M van Leeuwen, B G Molenkamp, J R M van der Sijp, S Meijer, P J van Diest.   

Abstract

AIMS: To evaluate in detail the extent to which step sectioning and immunohistochemical examination of sentinel lymph nodes (SLNs) in patients with melanoma reveal additional node positive patients, to arrive at a sensitive yet workable protocol for histopathological SLN examination.
METHODS: The study comprised 29 patients with one or more positive SLN after a successful SLN procedure for clinical stage I/II melanoma. SLNs were lamellated into pieces of approximately 0.5 cm in size. One initial haematoxylin and eosin (H&E) stained central cross section was made for each block. When negative, four step ribbons were cut at intervals of 250 microm. One section from each ribbon was stained with H&E, and one was used for immunohistochemistry (IHC).
RESULTS: When taking the cumulative total of detected metastases at level 5 as 100%, the percentage of SLN positive patients increased from 79%, 83%, 83%, 90% to 93% in the H&E sections through levels 1-5, and with IHC these values were 83%, 86%, 90%, 97%, and 100%, respectively. One of six patients in whom metastases were detected at levels 2-5 only had metastases in the subsequent additional lymph node dissection.
CONCLUSIONS: Multiple level sectioning of SLNs (five levels at 250 microm intervals) and the use of IHC detects additional metastases up to the last level in melanoma SLNs. Although more levels of sectioning might increase the yield even further, this protocol ensures a reasonable workload for the pathologist with an acceptable sensitivity when compared with the published literature.

Entities:  

Mesh:

Year:  2004        PMID: 15166267      PMCID: PMC1770332          DOI: 10.1136/jcp.2003.011742

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study.

Authors:  K Dowlatshahi; M Fan; K J Bloom; D J Spitz; S Patel; H C Snider
Journal:  Cancer       Date:  1999-09-15       Impact factor: 6.860

2.  Histopathological workup of sentinel lymph nodes: how much is enough?

Authors:  P J van Diest
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

Review 3.  Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

4.  Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes.

Authors:  J F Thompson; W H McCarthy; C M Bosch; C J O'Brien; M J Quinn; S Paramaesvaran; K Crotty; S W McCarthy; R F Uren; R Howman-Giles
Journal:  Melanoma Res       Date:  1995-08       Impact factor: 3.599

5.  Detection of microscopic melanoma metastases in sentinel lymph nodes.

Authors:  L L Yu; T J Flotte; K K Tanabe; M A Gadd; A B Cosimi; A J Sober; M C Mihm; L M Duncan
Journal:  Cancer       Date:  1999-08-15       Impact factor: 6.860

6.  Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.

Authors:  J E Gershenwald; W Thompson; P F Mansfield; J E Lee; M I Colome; C H Tseng; J J Lee; C M Balch; D S Reintgen; M I Ross
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

7.  Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.

Authors:  R R Turner; D W Ollila; D L Krasne; A E Giuliano
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

8.  The development of optimal pathological assessment of sentinel lymph nodes for melanoma.

Authors:  Martin G Cook; Margaret A Green; Brian Anderson; Alexander M M Eggermont; Dirk J Ruiter; Alain Spatz; Mark W Kissin; Barry W E M Powell
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

9.  Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy.

Authors:  H van der Veen; O S Hoekstra; M A Paul; M A Cuesta; S Meijer
Journal:  Br J Surg       Date:  1994-12       Impact factor: 6.939

10.  The orderly progression of melanoma nodal metastases.

Authors:  D Reintgen; C W Cruse; K Wells; C Berman; N Fenske; F Glass; K Schroer; R Heller; M Ross; G Lyman
Journal:  Ann Surg       Date:  1994-12       Impact factor: 12.969

View more
  6 in total

1.  The clinical importance of micrometastases within the lymphatic system in patients after total gastrectomy.

Authors:  Arkadiusz Spychała; Dawid Murawa; Konstanty Korski
Journal:  Rep Pract Oncol Radiother       Date:  2011-10-14

2.  Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells.

Authors:  Barbara G Molenkamp; Ronald J C L M Vuylsteke; Paul A M van Leeuwen; Sybren Meijer; Wim Vos; Pepijn G J T B Wijnands; Rik J Scheper; Tanja D de Gruijl
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

Review 3.  Importance of tumor load in the sentinel node in melanoma: clinical dilemmas.

Authors:  Alexander C J van Akkooi; Cornelis Verhoef; Alexander M M Eggermont
Journal:  Nat Rev Clin Oncol       Date:  2010-06-22       Impact factor: 66.675

4.  Detailed Lymph Node Sectioning of Papillary Thyroid Carcinoma Specimen Increases the Number of pN1a Patients.

Authors:  Felix Haglund; Stina Garvin; Catharina Ihre-Lundgren; Inga-Lena Nilsson; Evelina Hall; Tobias Carling; Anders Höög; C Christofer Juhlin
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

5.  Estimation of groin recurrence risk in patients with squamous cell vulvar carcinoma by the assessment of marker gene expression in the lymph nodes.

Authors:  Magdalena Kowalewska; Jakub Radziszewski; Krzysztof Goryca; Mateusz Bujko; Malgorzata Oczko-Wojciechowska; Michal Jarzab; Janusz Aleksander Siedlecki; Mariusz Bidzinski
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

6.  Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer.

Authors:  Mike Visser; Mehdi Jiwa; Anja Horstman; Antoinette A T P Brink; Rene P Pol; Paul van Diest; Peter J F Snijders; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2008-06-01       Impact factor: 7.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.